(Press-News.org) New Rochelle, NY, February 14, 2013—As scientists continue to unravel the complexity of the human genome and to uncover vital elements that play a role in both normal physiology and disease, one particular class of elements called noncoding RNAs is gaining a lot of attention. Guest Editor Tom Cech, PhD and Executive Editor Fintan Steele, PhD explore the enormous potential value of this rapidly advancing research area in their Editorial " The (Noncoding) RNA World." The authors introduce a special research section on noncoding RNAs published in the current issue of Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers. The Editorial is available free on the Nucleic Acid Therapeutics website.
Dr. Cech, a Howard Hughes Medical Institute investigator and the Director of The BioFrontiers Institute at the University of Colorado Boulder, notes in the Editorial that the special section on noncoding RNAs illustrates the exciting progress being made, particularly related to the potential for research advances to lead to the development of novel therapeutic and diagnostic interventions.
Yolanda Sánchez and Maite Huarte, University of Navarra, Pamplona, Spain, provide an overview of the role of long noncoding RNAs in various diseases. In "Long Non-Coding RNAs: Challenges for Diagnosis and Therapies," the authors also discuss the potential for targeting these RNAs for therapeutic and diagnostic applications. Maitri Shah and George Calin, The University of Texas MD Anderson Cancer Center, Houston, TX, explore the emerging concept that noncoding microRNAs in the circulation might function as hormones. What role these microRNAs might play in disease is also examined in "The Mix of Two Worlds: Non-Coding RNAs and Hormones." Marc Weinberg and Kevin Morris, The Scripps Research Institute, La Jolla, CA, describe current understanding of the regulatory function of long noncoding RNAs and how it might be used to create an entirely new area of pharmacology in "Long Non-Coding RNA Targeting and Transcriptional De-Repression."
"The astoundingly diverse roles of noncoding RNAs across many areas of biology and disease are among the most exciting areas of current research," says Executive Editor Fintan Steele, PhD, SomaLogic, Inc., Boulder, CO. "It is increasingly clear that as our knowledge of these molecules improves, so will potential therapeutic applications that take advantage of their unique biological properties."
INFORMATION:
Nucleic Acid Therapeutics is under the editorial leadership of Co-Editors-in-Chief Bruce A. Sullenger, PhD, Duke Translational Research Institute, Duke University Medical Center, Durham, NC, and C.A. Stein, MD, PhD, City of Hope National Medical Center, Duarte, CA; and Executive Editor Fintan Steele, PhD (SomaLogic, Boulder, CO).
About the Journal
Nucleic Acid Therapeutics is an authoritative, peer-reviewed journal published bimonthly in print and online that focuses on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. Nucleic Acid Therapeutics is the Official Journal of the Oligonucleotide Therapeutics Society. Complete tables of content and a free sample issue may be viewed on the Nucleic Acid Therapeutics website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative medical and biomedical peer-reviewed journals, including Metabolic Syndrome and Related Disorders, Population Health Management, Diabetes Technology & Therapeutics, and Journal of Women's Health. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, newsmagazines, and books is available on the Mary Ann Liebert, Inc., publishers website at http://www.liebertpub.com.
Mary Ann Liebert, Inc. 140 Huguenot Street, New Rochelle, NY 10801-5215 www.liebertpub.com
Phone (914) 740-2100 (800) M-LIEBERT Fax (914) 740-2101
Noncoding RNAs offer huge therapeutic and diagnostic potential
2013-02-15
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Building healthy bones takes guts
2013-02-15
EAST LANSING, Mich. — In what could be an early step toward new treatments for people with osteoporosis, scientists at Michigan State University report that a natural probiotic supplement can help male mice produce healthier bones.
Interestingly, the same can't be said for female mice, the researchers report in the Journal of Cellular Physiology.
"We know that inflammation in the gut can cause bone loss, though it's unclear exactly why," said lead author Laura McCabe, a professor in MSU's departments of Physiology and Radiology. "The neat thing we found is that a probiotic ...
New methodology to predict pandemics
2013-02-15
NEW YORK – February 13, 2013 – EcoHealth Alliance, the nonprofit organization that focuses on local conservation and global health issues, announced new research focused on the rapid identification of disease outbreaks in the peer reviewed publication, Journal of the Royal Society Interface. The article, authored by leading scientists in the fields of emerging disease ecology, biomathematics, computational biology and bioinformatics, shows how network theory can be used to identify outbreaks of unidentified diseases. The strategy builds on the wealth of online surveillance ...
Quantum cryptography put to work for electric grid security
2013-02-15
LOS ALAMOS, N.M., Feb. 14, 2013—A Los Alamos National Laboratory quantum cryptography (QC) team has successfully completed the first-ever demonstration of securing control data for electric grids using quantum cryptography.
The demonstration was performed in the electric grid test bed that is part of the Trustworthy Cyber Infrastructure for the Power Grid (TCIPG) project at the University of Illinois Urbana-Champaign (UIUC) that was set up under the Department of Energy's Cyber Security for Energy Delivery Systems program in the Office of Electricity Delivery and Energy ...
A microbial biorefinery provides new insight into how bacteria regulate genes
2013-02-15
PROVIDENCE, R.I. [Brown University] — Microorganisms that can break down plant biomass into the precursors of biodiesel or other commodity chemicals might one day be used to produce alternatives to petroleum. But the potential of this "biorefinery" technology is limited by the fact that most microorganisms cannot break down lignin, a highly stable polymer that makes up as much as a third of plant biomass.
Streptomyces bacteria are among few microorganisms known to degrade and consume lignin. Now a group of researchers at Brown University has unlocked the genetic and molecular ...
NASA's Fermi proves supernova remnants produce cosmic rays
2013-02-15
A new study using observations from NASA's Fermi Gamma-ray Space Telescope reveals the first clear-cut evidence the expanding debris of exploded stars produces some of the fastest-moving matter in the universe. This discovery is a major step toward understanding the origin of cosmic rays, one of Fermi's primary mission goals.
"Scientists have been trying to find the sources of high-energy cosmic rays since their discovery a century ago," said Elizabeth Hays, a member of the research team and Fermi deputy project scientist at NASA's Goddard Space Flight Center in Greenbelt, ...
Researchers discover breakthrough in ovarian cancer
2013-02-15
(Phoenix, AZ Feb. 14, 2014) -- Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors stabilize or shrink after taking a regular dose of the compound selumetinib.
The findings, published in the Feb. 14 edition of The Lancet Oncology, show that selumetinib targets a mutation in the MAPK pathway for patients with low-grade serous carcinoma, allowing for treatment on previously chemoresistant tumors.
"This ...
NASA satellite sees Cyclone Gino's rainfall shoved southward
2013-02-15
NASA's Tropical Rainfall Measuring Mission satellite known as TRMM measured Cyclone Gino's rainfall from space and saw the bulk of precipitation was south of the center. Gino's rainfall is being pushed away from the center by vertical wind shear.
TRMM flew over Cyclone Gino on Thursday, Feb. 14 at 0806 UTC (3:06 a.m. EST) and measured the rainfall rates occurring throughout the storm. The bulk of the rainfall stretched from south to southeast of the center. The heaviest rain was falling at a rate of 2 inches (50 mm) per hour southeast of the center, and scattered throughout ...
Prevention efforts focused on youth reduce prescription abuse into adulthood
2013-02-15
Middle school students from small towns and rural communities who received any of three community-based prevention programs were less likely to abuse prescription medications in late adolescence and young adulthood. The research, published today in the American Journal of Public Health, was funded by the National Institute on Drug Abuse (NIDA), the National Institute on Alcohol Abuse and Alcoholism, and the National Institute of Mental Health, all components of the National Institutes of Health.
"Prescription medications are beneficial when used as prescribed to treat ...
Research finds promising approaches to prevent Latino childhood obesity
2013-02-15
San Diego, CA, February 15, 2013 – Guided grocery store trips, menu labeling at restaurants, community gardens, and video-game-based exercise programs are among several promising, culturally appropriate ways to prevent obesity among Latino children, according to a new collection of studies from Salud America! The Robert Wood Johnson Foundation Research Network to Prevent Obesity Among Latino Children published in a supplement to the March issue of the American Journal of Preventive Medicine.
Salud America! is a national network of researchers, advocates, and policymakers ...
Moffitt researchers find potential new therapeutic target for treating non-small cell lung cancer
2013-02-15
Researchers at Moffitt Cancer Center have found a potential targeted therapy for patients with tobacco-associated non-small cell lung cancer. It is based on the newly identified oncogene IKBKE, which helps regulate immune response.
The study appeared in the Feb. 13 online issue of Oncogene.
The IKBKE gene is part of a family of enzyme complexes involved in increasing cellular inflammation. IKBKE overexpression has been associated with breast and prostate cancers. However, it had not been linked to environmental carcinogen, such as tobacco smoke, until now.
Tobacco ...